SGH Medical Technology - Managed Fund

The objective of the SGH Medical Technology managed fund is The investment manager seeks to achieve long-term capital growth by focusing stock selection on: 1. Share valuation 2. Company management and industry structure 3. Behavioural factors to determine investment-timing It is intended that the investment portfolio will consist of 40 to 60 companies split between: Mature Growth, Developing Growth, and Seed.

The strategy of the SGH Medical Technology managed fund is The investment manager seeks to achieve long-term capital growth by focusing stock selection on: 1. Share valuation 2. Company management and industry structure 3. Behavioural factors to determine investment-timing It is intended that the investment portfolio will consist of 40 to 60 companies split between: Mature Growth, Developing Growth, and Seed.

The APIR code of the SGH Medical Technology managed fund is ETL2825AU.

SGH Medical Technology’s total return last month was -5.49%. This was made up of a growth return of -0.43% and an income return of -5.06%. These returns were calculated as at 31 Jan 2026.

SGH Medical Technology’s total return for the last three months was -3.83%. This was made up of a growth return of -4.78% and an income return of 0.95%%. These returns were calculated as at 31 Jan 2026.

SGH Medical Technology’s one-year total return is -14.79%. This was made up of a growth return of -9.42% and an income return of -5.37%. These returns were calculated as at 31 Jan 2026.

SGH Medical Technology’s one-year total return is -0.69%. This was made up of a growth return of 0.32% and an income return of -1.01%. These returns were calculated as at 31 Jan 2026.

The asset allocation of the SGH Medical Technology managed fund is :

The Responsible Entity for the SGH Medical Technology managed fund is SG Hiscock & Company Limited.

The SGH Medical Technology managed fund belongs to the Equity Australia Other sector/asset class.

As at 11 Feb 2026, the size of the SGH Medical Technology managed fund was $4376880 million.

The SGH Medical Technology managed fund has an inception date of 30 Jun 2021.

The current entry price of the SGH Medical Technology managed fund is $0.766 per unit and the current exit price is $0.7606 per unit (as at 11 Feb 2026).

The current exit price of the SGH Medical Technology managed fund is $0.7606 per unit and the current entry price is $0.766 per unit (as at 11 Feb 2026).

The minimum initial investment amount for the SGH Medical Technology managed fund is $20,000. Minimum additional investment is $5000.